A change is taking place at the top at Analytik Jena. Managing Director Ulrich Krauss has decided to assume other responsibilities outside of Analytik Jena. The Endress+Hauser Group is therefore handing over the management of the subsidiary specializing in laboratory analysis to Oliver Klaeffling as of 1 February 2023.
Ulrich Krauss joined the Analytik Jena management team in 2015 and took over as managing director in 2016. “We would like to express our thanks to Mr Krauss for his commitment, in particular leading and overseeing the extensive reorganization processes at Analytik Jena, which contributed to the success of the Endress+Hauser Group,” said Matthias Altendorf, CEO of the Endress+Hauser Group. His successor, 53-year-old Oliver Klaeffling, studied industrial engineering at the Technical University of Berlin’s school of technical chemistry. He has held various positions in Germany and the US for pharmaceutical company Merck since 2004. He was most recently head of the Merck Innovation Center in Darmstadt, Germany. “We are convinced that Mr Klaeffling will continue to grow and lead Analytik Jena into a solid future,” emphasized Matthias Altendorf.
Investments in corporate development
Oliver Klaeffling will be supported by the existing five-member management team. Analytik Jena plays an important role toward Endress+Hauser’s strategic goal of supporting customers from the lab to production. The Group is currently investing 50 million euros in a modern company campus in Jena-Göschwitz, Germany; a new production facility is to be built in Ilmenau, Germany, at a cost of 27 million euros.